This clinical trial evaluates the noninferiority of high-flow nasal cannula (HFNC) therapy vs continuous positive airway pressure (CPAP) as the first-line mode of noninvasive respiratory support following extubation on time to liberation from respiratory support.
Source: JAMA Online First